Eikon Therapeutics buys global rights to several clinical-stage assets

By NS Healthcare Staff Writer

02 Jun 23

In addition to the transactions, Eikon has concluded the initial portion of a Series C equity financing, securing…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

InDex Pharmaceuticals, Viatris sign deal to commercialise cobitolimod in Japan

By NS Healthcare Staff Writer

01 Jun 23

Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Lexicon receives FDA approval for Inpefa to treat heart failure in adults

By NS Healthcare Staff Writer

29 May 23

Inpefa is an oral inhibitor of sodium-glucose cotransporter types 2 and 1 (SGLT2 and SGLT1), administered as a…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Artios Pharma to use ANGLE technology in cancer clinical trial

By NS Healthcare Staff Writer

25 May 23

With an extensive pipeline focused on DDR and strategic partnerships with global pharmaceutical companies, Artios has chosen ANGLE…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

CohBar, Morphogenesis announce merger to advance late-stage oncology pipeline

By NS Healthcare Staff Writer

24 May 23

Post-merger, the combined firm, which is expected to operate as TuHURA Biosciences and trade on Nasdaq Capital Market,…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Ironwood Pharmaceuticals to acquire Switzerland-based VectivBio for $1bn

By NS Healthcare Staff Writer

23 May 23

VectivBio’s lead investigational product is apraglutide, a next-generation, long-acting synthetic GLP-2 analog in phase 3, which is being…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

AVROBIO to sell HSC gene therapy programme to Novartis for $87.5m

By NS Healthcare Staff Writer

23 May 23

Switzerland-based Novartis will pay AVROBIO $87.5m in cash at closing as compensation for the sale and transfer of…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Amyris inks license agreement with Croda for sustainable squalene

By NS Healthcare Staff Writer

22 May 23

According to the terms of the contract, Croda will purchase a licence from Amyris to market, distribute, and…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

SERB obtains US rights to SFJ’s ticagrelor reversal agent bentracimab

By NS Healthcare Staff Writer

12 May 23

Bentracimab is a novel, monoclonal antibody fragment that reverses the antiplatelet activity of ticagrelor, an antiplatelet medicine marketed…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Sweden’s Sobi agrees to acquire CTI BioPharma for $1.7bn

By NS Healthcare Staff Writer

11 May 23

The transaction, which has been unanimously approved by the Board of Directors of both the companies, is expected…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates